医学
急性胰腺炎
病死率
胰腺炎
肠外营养
重症监护医学
抗生素
疾病
静脉注射抗生素
肠内给药
流行病学
内科学
儿科
微生物学
生物
作者
Tadahiro Takada,Shuji Isaji,Toshihiko Mayumi,Masahiro Yoshida,Yoshifumi Takeyama,Takao Itoi,Keiji Sano,Yusuke Iizawa,Atsushi Masamune,Morihisa Hirota,Kohji Okamoto,Dai Inoue,Nobuya Kitamura,Yasuhisa Mori,Shuntaro Mukai,Seiki Kiriyama,Kunihiro Shirai,Asuka Tsuchiya,Ryota Higuchi,Teijiro Hirashita
摘要
Abstract Background In preparing the Japanese (JPN) guidelines for the management of acute pancreatitis 2021, the committee focused the issues raised by the results of nationwide epidemiological survey in 2016 in Japan. Method In addition to a systematic search using the previous JPN guidelines, papers published from January 2014 to September 2019 were searched for the contents to be covered by the guidelines based on the concept of GRADE system. Results Thirty‐six clinical questions (CQ) were prepared in 15 subject areas. Based on the facts that patients diagnosed with severe disease by both Japanese prognostic factor score and contrast‐enhanced computed tomography (CT) grade had a high fatality rate and that little prognosis improvement after 2 weeks of disease onset was not obtained, we emphasized the importance of Pancreatitis Bundles, which were shown to be effective in improving prognosis, and the CQ sections for local pancreatic complications had been expanded to ensure adoption of a step‐up approach. Furthermore, on the facts that enteral nutrition for severe acute pancreatitis was not started early within 48 h of admission and that unnecessary prophylactic antibiotics was used in almost all cases, we emphasized early enteral nutrition in small amounts even if gastric feeding is used and no prophylactic antibiotics are administered in mild pancreatitis. Conclusion All the members of the committee have put a lot of effort into preparing the extensively revised guidelines in the hope that more people will have a common understanding and that better medical care will be spread.
科研通智能强力驱动
Strongly Powered by AbleSci AI